Insider · CIK 0001466562

Renz Justin A

Reports to the SEC for 4 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001466562

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-18	ZVRAZEVRA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	CFO	AAward	+300K sh	—	—	300,000
2025-08-21	ARDXARDELYX, INC.S Sale	Chief Financial Officer	SSale	−7,037 sh	$5.93	−$41.7K	409,052
2025-05-20	ARDXARDELYX, INC.S Sale	Chief Financial Officer	SSale	−7,218 sh	$4.08	−$29.5K	416,089
2025-02-25	ARDXARDELYX, INC.A Award	Chief Financial Officer	AAward	+137K sh	—	—	422,648
2025-02-25	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+205K sh	—	—	205,019
2025-02-20	ARDXARDELYX, INC.S Sale	Chief Financial Officer	SSale	−5,171 sh	$5.62	−$29.1K	285,968
2024-11-20	ARDXARDELYX, INC.S Sale	Chief Financial Officer	SSale	−5,260 sh	$4.79	−$25.2K	291,139
2024-08-20	ARDXARDELYX, INC.S Sale	Chief Financial Officer	SSale	−5,289 sh	$5.86	−$31K	295,257
2024-05-21	ARDXARDELYX, INC.S Sale	Chief Financial Officer	SSale	−5,167 sh	$7.81	−$40.4K	300,546
2024-02-20	ARDXARDELYX, INC.S Sale	Chief Financial Officer	SSale	−5,341 sh	$8.75	−$46.7K	304,835
2024-01-16	ARDXARDELYX, INC.A Award	Chief Financial Officer	AAward	+128K sh	—	—	310,176
2024-01-16	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+164K sh	—	—	164,000
2023-12-26	ARDXARDELYX, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+75K sh	$0.99	+$74.3K	407,426
2023-12-26	ARDXARDELYX, INC.S Sale	Chief Financial Officer	SSale	−225K sh	$6.36	−$1.43M	182,426
2023-12-26	ARDXARDELYX, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−75K sh	—	—	121,000
2023-11-20	ARDXARDELYX, INC.S Sale	Chief Financial Officer	SSale	−2,873 sh	$4.36	−$12.5K	332,426
2023-08-21	ARDXARDELYX, INC.S Sale	Chief Financial Officer	SSale	−2,884 sh	$3.55	−$10.2K	333,849
2023-05-23	ARDXARDELYX, INC.S Sale	Chief Financial Officer	SSale	−2,873 sh	$3.65	−$10.5K	336,733
2023-02-21	ARDXARDELYX, INC.S Sale	Chief Financial Officer	SSale	−3,439 sh	$3.00	−$10.3K	336,606
2023-01-05	ARDXARDELYX, INC.A Award	Chief Financial Officer	AAward	+78K sh	—	—	340,045
2023-01-05	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+351K sh	—	—	351,000
2022-11-22	ARDXARDELYX, INC.S Sale	Chief Financial Officer	SSale	−61 sh	$1.94	−$118.432	263,488
2022-11-22	ARDXARDELYX, INC.S Sale	Chief Financial Officer	SSale	−1,443 sh	$1.95	−$2,812.84	262,045
2022-08-31	ARDXARDELYX, INC.P Purchase	Chief Financial Officer	PPurchase	+3,000 sh	$0.62	+$1,856.4	263,549
2022-08-22	ARDXARDELYX, INC.S Sale	Chief Financial Officer	SSale	−1,480 sh	$0.98	−$1,455.876	260,567
2022-08-22	ARDXARDELYX, INC.S Sale	Chief Financial Officer	SSale	−6 sh	$0.98	−$5.881	260,561
2022-08-22	ARDXARDELYX, INC.S Sale	Chief Financial Officer	SSale	−12 sh	$0.98	−$11.761	260,549
2022-06-06	ARDXARDELYX, INC.S Sale	Chief Financial Officer	SSale	−71.8K sh	$0.65	−$46.7K	263,565
2022-06-06	ARDXARDELYX, INC.S Sale	Chief Financial Officer	SSale	−1,518 sh	$0.64	−$964.841	262,047
2022-05-20	ARDXARDELYX, INC.S Sale	Chief Financial Officer	SSale	−1,528 sh	$0.67	−$1,025.899	335,359
2022-02-22	ARDXARDELYX, INC.S Sale	Chief Financial Officer	SSale	−1,800 sh	$0.67	−$1,206	333,887
2022-01-06	ARDXARDELYX, INC.A Award	Chief Financial Officer	AAward	+42K sh	—	—	335,687
2022-01-06	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+196K sh	—	—	196,000
2021-11-22	ARDXARDELYX, INC.S Sale	Chief Financial Officer	SSale	−643 sh	$0.99	−$637.792	293,687
2021-10-08	ARDXARDELYX, INC.A Award	Chief Financial Officer	AAward	+250K sh	—	—	294,330
2021-08-20	ARDXARDELYX, INC.S Sale	Chief Financial Officer	SSale	−631 sh	$1.32	−$832.92	40,047
2021-05-20	ARDXARDELYX, INC.S Sale	Chief Financial Officer	SSale	−612 sh	$7.09	−$4,337.734	40,678
2021-02-22	ARDXARDELYX, INC.S Sale	Chief Financial Officer	SSale	−608 sh	$6.88	−$4,184.56	41,290
2021-01-05	ARDXARDELYX, INC.A Award	Chief Financial Officer	AAward	+32.6K sh	—	—	41,898
2021-01-05	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+147K sh	—	—	146,755
2020-09-15	ARDXARDELYX, INC.S Sale	Chief Financial Officer	SSale	−3,714 sh	$5.49	−$20.4K	9,286
2020-06-08	ARDXARDELYX, INC.A Award	Chief Financial Officer	AAward	+10K sh	—	—	13,000
2020-06-08	ARDXARDELYX, INC. · Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+195K sh	—	—	195,017
2017-01-20	KPTIKaryopharm Therapeutics Inc. · Stock Option (right to buy)A Award	EVP, CFO & Treasurer	AAward	+100K sh	—	—	100,000
2016-11-09	KPTIKaryopharm Therapeutics Inc.S Sale	EVP, CFO & Treasurer	SSale	−4,342 sh	$8.19	−$35.5K	19,173
2016-11-05	KPTIKaryopharm Therapeutics Inc.M Exercise/Conversion	EVP, CFO & Treasurer	MExercise/Conversion	+15K sh	—	—	23,515
2016-11-05	KPTIKaryopharm Therapeutics Inc. · Restricted Stock UnitsM Exercise/Conversion	EVP, CFO & Treasurer	MExercise/Conversion	−15K sh	—	—	15,000
2016-01-15	KPTIKaryopharm Therapeutics Inc. · Stock Option (right to buy)A Award	EVP, CFO & Treasurer	AAward	+100K sh	—	—	100,000
2015-11-05	KPTIKaryopharm Therapeutics Inc. · Restricted Stock UnitsA Award	EVP, CFO & Treasurer	AAward	+30K sh	—	—	30,000
2015-04-02	KPTIKaryopharm Therapeutics Inc.P Purchase	EVP, CFO & Treasurer	PPurchase	+5,000 sh	$29.71	+$149K	5,000

Recent filings

Accepted (ET)
Mar 194
Renz Justin A0001466562-26-000007
SEC(opens sec.gov)
Aug 254
Renz Justin A0001628280-25-041137
SEC(opens sec.gov)
May 224
Renz Justin A0001628280-25-027431
SEC(opens sec.gov)
Feb 274
Renz Justin A0001628280-25-008798
SEC(opens sec.gov)
Feb 214
Renz Justin A0001628280-25-007232
SEC(opens sec.gov)
Nov 224
Renz Justin A0001628280-24-049053
SEC(opens sec.gov)
Aug 224
Renz Justin A0001628280-24-038291
SEC(opens sec.gov)
May 234
Renz Justin A0001628280-24-024944
SEC(opens sec.gov)
Feb 224
Renz Justin A0001610717-24-000087
SEC(opens sec.gov)
Jan 184
Renz Justin A0001628280-24-001684
SEC(opens sec.gov)
Dec 284
Renz Justin A0001628280-23-042828
SEC(opens sec.gov)
Nov 224
Renz Justin A0001628280-23-039902
SEC(opens sec.gov)
Aug 234
Renz Justin A0001628280-23-030404
SEC(opens sec.gov)
May 254
Renz Justin A0001104659-23-064390
SEC(opens sec.gov)
Feb 244
Renz Justin A0001567619-23-003769
SEC(opens sec.gov)
Jan 64
Renz Justin A0001567619-23-000645
SEC(opens sec.gov)

Companies

Address

C/O ZEVRA THERAPEUTICS, INC. 101 FEDERAL STREET

BOSTON, MA, 02110